FORA Capital’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

FORA Capital’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-34,971	Closed	-$1.68M	–	1476
2020 Q1	$1.68M	Buy	+34,971	New	+$1.63M	0.36%	58

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

FORA Capital's RARX Position: Q2 2020 in Review

FORA Capital sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 34,971 shares — an estimated $1.68M sold.

FORA Capital first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $1.68M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

FORA Capital reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
FORA Capital sold 34,971 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $1.68M.
FORA Capital first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
FORA Capital's Ra Pharmaceuticals, Inc. Common Stock position peaked at $1.68M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on FORA Capital's 13F filing for Q2 2020, filed 14 Aug 2020.